The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $19.45

Today's change-0.03 -0.15%
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $19.45

Today's change-0.03 -0.15%
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.

Meridian Bioscience Inc down (U.S.)$0.03

Meridian Bioscience Inc closed lower Wednesday, dropping (U.S.)$0.03 or 0.15% to (U.S.)$19.45. Over the last five days, shares have gained 2.37%, but are down 5.21% for the last year to date. Shares have underperformed the S&P 500 by 8.41% during the last year.

Key company metrics

  • Open(U.S.) $19.42
  • Previous close(U.S.) $19.48
  • High(U.S.) $19.62
  • Low(U.S.) $19.22
  • Bid / Ask(U.S.) $17.20 / (U.S.) $19.45
  • YTD % change-5.21%
  • Volume199,057
  • Average volume (10-day)200,893
  • Average volume (1-month)214,681
  • Average volume (3-month)217,326
  • 52-week range(U.S.) $16.60 to (U.S.) $21.49
  • Beta1.08
  • Trailing P/E23.38×
  • P/E 1 year forward22.65×
  • Forward PEG1.42×
  • Indicated annual dividend(U.S.) $0.80
  • Dividend yield4.11%
  • Trailing EPS(U.S.) $0.83
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.59%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue51514747
Total other revenue--------
Total revenue51514747
Gross profit33343230
Total cost of revenue18181617
Total operating expense37363434
Selling / general / administrative16151514
Research & development4333
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0------
Other operating expenses, total--------
Operating income14151413
Interest income (expense), net non-operating00----
Gain (loss) on sale of assets--------
Other--------
Income before tax13151413
Income after tax9998
Income tax, total5655
Net income9998
Total adjustments to net income--------
Net income before extra. items9998
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9998
Inc. avail. to common incl. extra. items9998
Diluted net income9998
Dilution adjustment--0----
Diluted weighted average shares42424242
Diluted EPS excluding extraordinary itemsvalue per share0.210.210.210.20
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.210.210.210.20